Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy

NCT01915615 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT01915615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01915615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
Lead sponsor
University of Virginia
Phase
Observational
Overall status
Active, not recruiting
Start date
April 30, 2014
Completion date
June 30, 2025
Enrollment
2,750 (estimated)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic cardiomyopathy